It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disease. It is thought that many common variant gene loci of weak effect act additively to predispose to common autoimmune diseases, while the contribution of rare variants remains unclear. Here we describe that rare coding variants in lupus-risk genes are present in most SLE patients and healthy controls. We demonstrate the functional consequences of rare and low frequency missense variants in the interacting proteins BLK and BANK1, which are present alone, or in combination, in a substantial proportion of lupus patients. The rare variants found in patients, but not those found exclusively in controls, impair suppression of IRF5 and type-I IFN in human B cell lines and increase pathogenic lymphocytes in lupus-prone mice. Thus, rare gene variants are common in SLE and likely contribute to genetic risk.
Function-altering variants of immune-related genes cause rare autoimmune syndromes, whereas their contribution to common autoimmune diseases remains uncharacterized. Here the authors show that rare variants of lupus-associated genes are present in the majority of lupus patients and healthy controls, but only the variants found in lupus patients alter gene function.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 John Curtin School of Medical Research, Department of Immunology and Infectious Disease, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.1001.0); The Canberra Hospital, Department of Renal Medicine, Garran, Australia (GRID:grid.413314.0) (ISNI:0000 0000 9984 5644)
2 John Curtin School of Medical Research, Department of Immunology and Infectious Disease, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.1001.0)
3 NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.1001.0); John Curtin School of Medical Research, Genome Informatics Laboratory, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477)
4 John Curtin School of Medical Research, Department of Immunology and Infectious Disease, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.1001.0); Translational Health Science and Technology Institute, Paediatric Biology Center, Faridabad, India (GRID:grid.464764.3) (ISNI:0000 0004 1763 2258)
5 Baylor Medical Institute, Houston, USA (GRID:grid.464764.3)
6 John Curtin School of Medical Research, Department of Immunology and Infectious Disease, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477)
7 John Curtin School of Medical Research, Department of Immunology and Infectious Disease, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); Trakya University, Department of Genetics and Bioengineering, Edirne, Turkey (GRID:grid.411693.8) (ISNI:0000 0001 2342 6459)
8 University of Zagreb School of Medicine, Department of Paediatric Rheumatology and Immunology, Zagreb, Croatia (GRID:grid.4808.4) (ISNI:0000 0001 0657 4636)
9 University Children’s Hospital, Medical School, Skopje, Macedonia (GRID:grid.4808.4)
10 Department of Pediatric Nephrology, Fundeni Clinical Institute, Bucharest, Romania (GRID:grid.415180.9) (ISNI:0000 0004 0540 9980)
11 NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.415180.9); Westmead Children’s Hospital, Westmead, Australia (GRID:grid.415180.9)
12 NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.415180.9); Monash University, Centre for Inflammatory Diseases, Department of Medicine, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
13 John Curtin School of Medical Research, Department of Immunology and Infectious Disease, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.1001.0); The Canberra Hospital, Department of Immunology, Garran, Australia (GRID:grid.413314.0) (ISNI:0000 0000 9984 5644)
14 JiaoTong University Shanghai, China Australia Centre for Personalised Immunology, Renji Hospital Shanghai, Huangpu Qu, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)
15 John Curtin School of Medical Research, Department of Immunology and Infectious Disease, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.1001.0); JiaoTong University Shanghai, China Australia Centre for Personalised Immunology, Renji Hospital Shanghai, Huangpu Qu, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)
16 The Canberra Hospital, Department of Immunology, Garran, Australia (GRID:grid.413314.0) (ISNI:0000 0000 9984 5644)
17 Walter and Eliza Hall Institute, Parkville, Australia (GRID:grid.1042.7)
18 Immunology PathWest Fiona Stanley Hospital, Murdoch, Australia (GRID:grid.459958.c) (ISNI:0000 0004 4680 1997)
19 Children’s University Hospital Niño Jesús, Department of Pediatric Nephrology, Madrid, Spain (GRID:grid.411107.2) (ISNI:0000 0004 1767 5442)
20 Research School of Biology and Research School of Finance, Actuarial Studies and Statistics, Acton, Australia (GRID:grid.411107.2)
21 NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.411107.2); Australian Phenomics Facility, ANU, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477)
22 NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.1001.0); John Curtin School of Medical Research, Genome Informatics Laboratory, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); National Computational Infrastructure, ANU, Acton, Australia (GRID:grid.474065.4)
23 NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.474065.4); John Curtin School of Medical Research, Genome Informatics Laboratory, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477)
24 Baylor Medical Institute, Houston, USA (GRID:grid.1001.0)
25 John Curtin School of Medical Research, Department of Immunology and Infectious Disease, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); NHMRC Centre for Research Excellence, Centre for Personalised Immunology, Acton, Australia (GRID:grid.1001.0); The Canberra Hospital, Department of Immunology, Garran, Australia (GRID:grid.413314.0) (ISNI:0000 0000 9984 5644); JiaoTong University Shanghai, China Australia Centre for Personalised Immunology, Renji Hospital Shanghai, Huangpu Qu, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)